GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Raiders flex their financial muscle with a massive free agency haul, including a record Tyler Linderbaum deal, aiming to end their playoff drought and compete in the tough AFC West....
Iranian officials selected Mojtaba Khamenei, the son of the late supreme leader, Ayatollah Ali Khamenei, to lead the Islamic Republic......
On Monday, the U.S.–Israel war with Iran pushed oil prices to their highest level since July 2022. Since the war......
